Delivery Order SPE2DB25D3020-SPE2DB25FWJST
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- On September 2, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. Ofev (nintedanib) is a prescription medication used in the treatment of certain pulmonary conditions, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $51,543.48 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of October 2, 2025, and represents a non-competitive set-aside award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ofev is a specialty pharmaceutical used primarily in...
- The Defense Logistics Agency awarded a $43,151.40 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in quantities of 60 units. This is a firm fixed price contract with an ultimate completion date of October 8, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $8.6K to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis and other progressive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg on July 25, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be performed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count unit) on September 18, 2025, with an ultimate completion date of October 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The order carries a ceiling value of $17,181.16 under a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award represents a non-set-aside, competitively awarded contract issued to the Conshohocken, Pennsylvania-based pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used in the treatment of pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJSTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialized pharmaceutical used primarily in the treatment of pulmonary fibrosis and other chronic lung conditions, reflecting the Defense Logistics Agency's procurement of specialty medications for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated consistent capability to meet federal medical procurement requirements through competitive awards, supplying critical medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/28/25 |